Drug Discovery and Development: Does the maturity of biotech companies affect their stock return volatility?
Stock return volatility is very high in the biotech industry opposed to other industries and there is limited explanation as to why. Biotech companies invest large amounts of money on research and development to move drugs forward in the clinical trial phases, to get market approval by the regulatory agency FDA. The drug discovery and development process is long and expensive, taking on average 12